Content about XML

September 18, 2014

Thank you for registering for the 2014 CSBA/SGRC Retreat! If you have any question please contact Caitlin Van Sant at cvansant@bio.org.

August 18, 2014

Chair: Ronald Stotish, Chief Executive Officer, Aqua Bounty Technologies, Inc.        
Vice Chair: Robin Readnour, Senior Director, Technology Acquisition & Biological Product Development, Elano, Inc.
Staff Contact: Cathleen Enright, Executive Vice President, Food & Agriculture, cenright@bio.org.   

August 18, 2014

Chair: Adam Monroe, President,  Novozymes North America, Novozymes 
Staff Contact: Brent Erickson, Executive Vice President, Industrial & Environmental, berickson@bio.org.  

August 18, 2014

Chair: David Pyott, Chairman & CEO, Allergan, Inc. 
Staff Contact: Joseph Damond, Senior Vice President, International Affairs, jdamond@bio.org  

Description:The committee oversees, in conjunction with other relevant BIO committees, BIO’s international work plan objectives to foster an environment conducive to biotechnology, re-shape the debate on IP and pro-innovation policies, and influence regulatory reform and harmonization discussions in key international markets.  The committee’s jurisdiction includes oversight of BIO’s International Affairs Initiative, international organization matters (e.g., WHO, WTO, WIPO, APEC, OECD), international advocacy and education programs, international studies, and coordinating efforts of foreign peer organizations.

Chair: David Pyott, Chairman & CEO, Allergan, Inc. 
Staff Contact: Joseph Damond, Senior Vice President, International Affairs, jdamond@bio.org

August 18, 2014

Chair: Scott Kohne, Market Acceptance Manager, NAFTA, Bayer CropScience, Inc.
Vice Chair: Jeffrey Nawn, Senior Manager, Biotech Affairs and Regulatory, Dupont Pioneer
Staff Contact: Adrianne Massey, Managing Director, Science & Regulatory Affairs, amassey@bio.org.

June 23, 2014

While not immune to the economic crisis and resulting recession, the bioscience industry weathered difficult economic times better than most industries, and is on course to regain its previous high employment levels. Indeed, the promise of bioscience-based solutions to global.

While not immune to the economic crisis and resulting recession, the bioscience industry weathered difficult economic times better than most industries, and is on course to regain its previous high employment levels. Indeed, the promise of bioscience-based solutions to global grand challenges in human health, food security, sustainable industrial production and environmental protection provides an optimistic picture for the biosciences as a key economic development engine in the U.S.

June 23, 2014

The Jumpstart Our Business Startup (JOBS) Act marks a key departure from the previous one-size-fits-all regulatory approach for companies conducting a public offering.

June 13, 2014

HealthTech Conference 2014 attendees receive a discounted rate to BIO 2014. Choose your registration type:

•   Convention Access, use code WLSA14CA
•   Education & Exhibition Access, use code WLSA14
•   Exhibition Access, use code WLSA14X

To compare registration packages and to register for BIO 2014, visit this page: http://convention.bio.org/register/

May 19, 2014
Synthetic biology is an extension of the continuum of genetic science that has been used safely for more than 40 years by the biotechnology industry in development of commercial
products. In this document, several of BIO's Industrial & Environmental Section member companies have provided examples of their companies' stories and' technology which tuliuze the technology of synthetic biology.  

While the term “synthetic biology” is relatively new, the science is not. Synthetic biology is in fact an evolution of biotechnology and it has been safely used in the development of products that hold benefits for society. A moratorium on science would harm patients waiting for cures as well as consumers seeking environmentally preferable alternatives to petrochemical-derived products.

May 2, 2014

Using an advanced form of genetic engineering, scientists are manipulating the structure of cells to create new life forms designed to perform specific functions, such as detecting arsenic in drinking water or producing biofuels from algae. 

 

March 31, 2014

Position Title: Manager, Industry Research & Event Programs
Department:  Business Development
Reports to: Vice President, Business Operations
Position summary: 

March 26, 2014

Although observers have been arguing for many years that conflicts of interest in medical research hurt patient care and diminish research integrity, the issue has lately become particularly salient to policy makers, researchers, institutions, and other stakeholders. The result is an environment with increased suspicion about the relationships between industry, research institutions, and physicians and greater regulation of these relationships.

Although observers have been arguing for many years that conflicts of interest in medical research hurt patient care and diminish research integrity, the issue has lately become particularly salient to policy makers, researchers, institutions, and other stakeholders. The result is an environment with increased suspicion about the relationships between industry, research institutions, and physicians and greater regulation of these relationships.

March 26, 2014

Patient requests for access to drugs and biologics prior to their approval has long created a dilemma for biotechnology companies. This document provides "Points to Consider" for biotechnology companies confronting these issues.

Patient requests for access to drugs and biologics prior to their approval has long created a dilemma for biotechnology companies. This document provides "Points to Consider" for biotechnology companies confronting these issues.

Read the document (183 KB PDF)

March 11, 2014

We are the world’s largest biotechnology trade association providing advocacy, business development, and communications services for more than 1,000 members around the world.

We champion biotechnology and advocate for our members – both large and small.

We represent companies at all stages of development, from start-ups to Fortune 500s.

Members focus on:

March 11, 2014

Our members are integral in the development of our advocacy efforts, and this takes shape in the form of staff-level committees. Through these committees, our members have a seat at the table to effectively influence our policy development and public outreach.

Areas of focus include:

December 13, 2013

Position Title: Associate/Deputy General Counsel* for Agriculture & Environment

            (*Exact title will depend on seniority of individual hired for the position)

Department: Legal and Intellectual Property

Reports to: General Counsel & Head of Public Policy    

September 26, 2013

Position Title:            Assistant, Vaccines, Biodefense and Diagnostics Policy

Department:          Policy

August 28, 2013

Got questions? This page might have your answer. 

Q. Is there a cost to speak? 
A. This differs for each event. Generally, speakers in breakout sessions may be given complimentary registrations whereas all company presentations require registrations. There are discounted packages available. 

August 28, 2013

Increased Visibility = Increased Opportunity
Click to find out more

 

Increased Visibility = Increased Opportunity

BIO speakers represent the most thought-provoking, diverse talents from all corners of the industry – healthcare, to industrial and environmental, to finance and business development.

Benefits of speaking at a BIO event, where innovation and education come together, include:

August 21, 2013

YES!  I want to join BIO PAC and help advocate biotechnology.  I understand that my personal contribution is completely voluntary and will be used to support the campaigns of candidates for federal office.

August 21, 2013

YES! I want to support BIO PAC and help advocate biotechnology. BIO PAC financially supports candidates who understand our industry. I understand that my personal contribution is completely voluntary and will be used to support the campaigns of candidates for federal office.

August 9, 2013

Be a Thought Leader at an Upcoming BIO Event

BIO offers a plethora of speaking opportunities throughout the year all over the globe. Share your expertise in front of key decision makers in the biotechnology field. Select your BIO platform based upon your regional or industry expertise: